Trial Profile
Phase III Clinical Study of DU-176b (Venous Thromboembolism): Japanese, Multicenter, Open-label Study of DU-176b in Patients With Severe Renal Impairment (SRI) Undergoing Orthopedic Surgery of the Lower Limbs
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary) ; Fondaparinux sodium
- Indications Venous thromboembolism
- Focus Adverse reactions; Pharmacokinetics; Registrational
- Sponsors Daiichi Sankyo Inc
- 25 Feb 2015 According to ClinicalTrials.gov record, number of treatment arms has been amended from 3 to 4.
- 12 Dec 2014 New trial record